Chairman of the Board and Acting CEO; Managing Director, Walter Greenblatt & Associates: Walter founded WG&A in 1998 focused solely on early stage life science companies. Since 2002, the firm has raised $122M in seed and Series A round capital for early stage life science companies and returned, to date, $622M to investors in those rounds. An experienced entrepreneur and “hands-on” operating executive, Walter has founded and grown to profitability a series of successful operating businesses. Earlier in his career he worked as a strategic consultant at Bain & Company in a variety of industries in including healthcare. Walter holds an BS from Yale University, an MA from Oxford University and an MBA from Harvard Business School.
Acting Chief Financial Officer; Vice President, Walter Greenblatt & Associates: Ezra is an experienced investment banking and valuation professional with more than 20 years’ experience in those fields. Ezra holds an BA from Oberlin College, an MA from Princeton University and an MBA from Rutgers University.
Acting Chief Operating Officer: Kathleen has in depth cross functional proficiency, encompassing R&D, Commercial, Finance, Investor Relations. Manufacturing, Regulatory with expertise in Marketing in both large and small company settings in both diagnostic and therapeutic pharmaceutical portfolios; Previous roles: Chief Operating Officer, Photocure ASA, GE Healthcare Medical Diagnostics, Chief Marketing Officer, Bristol-Myers Squibb Co, Vice President Oncology Marketing, US; Senior Director, Worldwide Oncology Franchise Mgmt. Kathleen holds a Pharm D and a BS Pharmacy from Purdue University School of Pharmacy.
Bela Denes, M.D.
Acting Chief Medical Officer: Dr. Bela Denes is an experienced physician with a long track record of advising medical companies of all sizes on a range of topics including strategy, clinical trials, licensing and many others. He was a senior medical lead in the clinical trials for a number of high profile urology drugs including Viagra and Cialis. He also holds several patents and is the Editor and Medical Director of Urotherapies.com. Previous roles: Amgen, Senior Director Medical Affairs, Genomic Health, Inc., Chief Clinical Advisor, UroSee Corporation, Chief Medical Office, Clarus Therapeutics. Bela holds a AB and an MD from Washington University in St. Louis.
John David Wilson
Preclinical/Regulatory: JD is a regulatory professional with over twenty years of drug development experience in the pharmaceutical industry, including project management, reviewing data, and composing high quality nonclinical documents for submission to global regulatory authorities. JD enjoys a successful track record in clinical trial application and marketing application approvals. Previous role Global Regulatory Project Manager, GlaxoSmithKline Inc. JD Wilson holds a BA from UNC and a Masters of Toxicology from NC State.